We just received data on a new analyst forecast for $BCAX. Eva Fortea Verdejo from Wells Fargo set a price target of 8.0 for BCAX. Multiple analysts have issued price ...
In a report released yesterday, Eva Fortea Verdejo from Wells Fargo reiterated a Buy rating on Celcuity, with a price target of $166.00. The company’s shares closed yesterday at $111.05. TipRanks has ...
Eva Fortea Verdejo is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is one of the most promising mid-cap healthcare stocks under $50. On December 12, Wells Fargo analyst Eva Fortea Verdejo indicated her bullish ...
In a report released yesterday, Eva Fortea Verdejo from Wells Fargo assigned a Buy rating to Genmab, with a price target of $40.00. The company’s shares closed yesterday at $25.45. Unlock trusted, ...
Forecasting The Future: 4 Analyst Projections For Zymeworks Forecasting The Future: 11 Analyst Projections For Exelixis The Analyst Verdict: Arcus Biosciences In The Eyes Of 5 Experts The Analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results